In this phase III trial, patients with TNBC were randomly assigned, after stratification by stage and menopausal status, to receive neoadjuvant chemotherapy comprising once-per-week carboplatin (AUC-2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results